Strand Therapeutics

company

About

Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.

Details

Last Funding Type
Series A
Last Funding Money Raised
$45M
Industries
Biotechnology,Life Science,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2017
Number Of Employee
51 - 100
Operating Status
Active
Legal Name
Strand Therapeutics Inc.

Strand Therapeutics is a developer of a biotechnology platform intended to create gene therapies powered by synthetic biology.The company's offerings include immunotherapies to help cells produce target cancer-killing proteins during immunotherapy, enabling patients to improve their body's immune system to fight cancer.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
6
$104.20M
Strand Therapeutics has raised a total of $104.20M in funding over 2 rounds. Their latest funding was raised on Nov 28, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 28, 2022 Series A $45M 4 FPV Ventures Detail
Nov 9, 2021 Grant $400K 1 National Cancer Institute Detail
Aug 4, 2021 Grant $800K 1 National Cancer Institute Detail
Jun 23, 2021 Series A $52M 5 Detail
Jun 4, 2019 Seed $6M 4 Playground Global Detail

Investments

Number of Investments
Number of Lead Investments
2
0
Strand Therapeutics has made 2 investments. Their most recent investment was on Aug 10, 2021, when WorkMotion raised €20.48M.
Date Company Name
Round Money Raised Industry Lead Investor
Aug 10, 2021 WorkMotion
Series A €20.48M Compliance
Mar 9, 2021 WorkMotion
Angel €2.20M Compliance

Investors

Number of Lead Investors
Number of Investors
4
12
Strand Therapeutics is funded by 12 investors. FPV Ventures and National Cancer Institute are the most recent investors.
Investor Name Lead Investor Funding Round
FPV Ventures Yes Series A
National Cancer Institute Yes Grant
Eli Lilly & Company Foundation Series A
Playground Global Series A
Potentum partners Series A
ANRI Series A
BeiGene Series A
Camford Capital Series A
Redmile Group Series A
Creative Destruction Lab (CDL) Seed

Employee Profiles

Number of Employee Profiles
9
Strand Therapeutics has 9 current employee profiles, including Board member Jory Bell
Board member
Executive
Advisor
Executive
Executive